Capsular tension ring decreases PCO after surgery

Article

Implantation of a capsular tension ring effectively reduces the percentage area of posterior capsular opacification (PCO) and the Nd:YAG laser capsulotomy rate in patients with highly myopic eyes, according to researchers in Albania and Turkey.

Implantation of a capsular tension ring effectively reduces the percentage area of posterior capsular opacification (PCO) and the Nd:YAG laser capsulotomy rate in patients with highly myopic eyes, according to researchers in Albania and Turkey.

The researchers conducted a prospective, single-surgeon, standardized-surgical-procedure fellow-eye comparison trial in which 34 highly myopic patients had phacoemulsification surgery.

All of the patients received an acrylic intraocular lens (IOL) and a capsular tension ring in one eye; the other eye served as a control by receiving the IOL only. The researchers documented PCO within the capsulorhexis overlap using standardized digital retroillumination images at least 2 years postoperatively and scored the percentage area of PCO. The researchers also determined the PCO score and the incidence of Nd: YAG capsulotomy of the eyes.

The researchers found that the PCO score of the eyes with a capsular tension ring was significantly lower (5.9 ± 4.3) than that of the controls (22.3 ± 12.2) (P P = 0.025).

"Even though [capsular tension ring] implantation is not routine in cataract surgery, its implantation should be considered in high myopic patients who have zonular instability and retinal pathologies posing risk for Nd:YAG capsulotomy," the researchers wrote.

Read the entire study in the Indian Journal of Ophthalmology.

Related Videos
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
Marjorie Rah, OD, PhD, FAAO
Giulia Corradetti, MD, discusses her presentation "Functional Microperimetric Correlates of OCT Structures Features in Intermediate AMD"
At this year's ARVO meeting, Paolo Silva, MD, presented data on Protocol AA on behalf of the DRCR Retina Network
© 2024 MJH Life Sciences

All rights reserved.